Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.
about
Multimodality treatment of brain metastases: an institutional survival analysis of 275 patientsSurgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastasesWhole brain radiotherapy for the treatment of newly diagnosed multiple brain metastasesSurgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastasesWhole brain radiotherapy for the treatment of multiple brain metastasesStereotactic radiosurgery (SRS) in the modern management of patients with brain metastasesNational consensus in China on diagnosis and treatment of patients with advanced breast cancerColorectal cancer: Metastases to a single organCombining radiotherapy with sunitinib: lessons (to be) learnedThe role of magnetic resonance imaging in the management of brain metastases: diagnosis to prognosisThe biology of radiosurgery and its clinical applications for brain tumors.Role of stereotactic radiosurgery in patients with more than four brain metastasesIncidence and treatment of brain metastasis in patients with esophageal carcinomaManagement of solitary and multiple brain metastases from breast cancerMelanoma brain metastases: an unmet challenge in the era of active therapyAdvances in treatment of brain metastases from primary non-small cell lung cancerIs upfront stereotactic radiosurgery a rational treatment option for very elderly patients with brain metastases? A retrospective analysis of 106 consecutive patients age 80 years and olderLong-term survival in a patient with multiple brain metastases from small-cell lung cancer treated with gamma knife radiosurgery on four occasions: a case reportThe RSSearch™ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapyThe role of radiosurgery to the tumor bed after resection of brain metastases.Optimizing contrast-enhanced magnetic resonance imaging characterization of brain metastases: relevance to stereotactic radiosurgery.Preoperative diffusion-weighted imaging of single brain metastases correlates with patient survival times.Stereotactic radiosurgery at St. Bartholomew's hospital: third quinquennial review.Single brain metastasis: radiosurgery alone compared with radiosurgery plus up-front whole-brain radiotherapy.Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study.Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) dataResection versus radiosurgery for patients with brain metastases.[Melanoma brain metastases : Treatment options].Treatment trends for patients with brain metastases: Does practice reflect the data?Treatment options for limited or symptomatic metastatic melanoma.Brain metastases as the only manifestation of an undetected primary tumor.Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis.Prognostic factors affecting the outcome of brain metastases from breast cancer.Whole brain radiation therapy in management of brain metastasis: results and prognostic factors.EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force.Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of lifeWhole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.Recursive partitioning analysis of prognostic factors for patients with four or more intracranial metastases treated with radiosurgery.Outcome of whole-brain irradiation for breast cancer patients.Single session stereotactic radiosurgery boost to the post-operative site in lieu of whole brain radiation in metastatic brain disease.
P2860
Q21245574-28E82CBD-DF67-4C52-AE2D-D57A1271395DQ24198129-89DD5205-173E-484F-904B-C70D5D460CFEQ24200466-43F245C9-3BE0-412E-89F1-453E1875A264Q24235688-F41A4C2F-9528-446A-BDFD-52D2FF910D11Q24245002-0E339E09-18B3-40A1-99D1-13969CC8019FQ26768667-A60211B4-AF2D-4893-9680-74273094409AQ26775621-FFE3382B-9F4B-4FA6-9FA2-1E915259AAD1Q26778009-7F8FB442-2627-4B91-A272-00B1230C367FQ26800587-271C1FF0-464E-4D7D-99AF-C484C43E76DEQ26825055-AF45B2E0-4B4C-41FA-8829-9F7A08BD91D5Q26829154-48E48B38-55DF-4602-A402-99A992D4BF20Q26851819-6E872F30-E22B-48B6-A8ED-4F4CF59B0EB8Q26853668-ADDC6DAA-191B-49F4-BF34-972D7683CA9FQ26865562-BC084B35-4106-4E4D-A1F7-643F32DDAB77Q26995622-90F48DB2-DB93-4B78-BA5D-1A42FE2DFF9DQ27022452-309DA880-B5B5-4FB0-902A-5E78A82A3D4AQ28396583-E430E6BA-A936-4CB8-86F2-44B9FCDA7619Q30424457-A96251DF-40E0-45C2-BDB5-D6A4DBA17193Q30443893-D4ADD532-5787-45A9-90F4-E1D6C95243ECQ30456299-DB1AA339-B481-426F-A784-597B6AE4923CQ30586979-2A3B7D5D-CA6F-4B0F-84F8-7B8CFA46ABE6Q30587443-96126967-9D1F-4607-B51F-4ED58A4BFBE8Q30987836-B7801B82-1D97-4024-A455-59A6553702CFQ31039691-4260468A-DBAC-4BE2-9412-15C3F95F4052Q31051761-255C9149-A176-41D4-9DD4-591ECBF65463Q31072630-157F1314-3702-49DF-990D-06AC42172594Q31097790-37953A0E-7E3B-4DD2-A7F4-E7B0CBDB8B8CQ31098294-117A7799-41E6-4451-AC60-B6B9717806C4Q31160473-D14E428D-D4FE-467F-8035-67E736422D0AQ31161199-A014CF08-3C3E-4862-8CBA-16ABFBAD3149Q31967363-B026996B-3837-4C22-9AE1-60017D9BCDD5Q33222212-349ED9DB-BB99-4389-BA8C-8B8EA387EC27Q33238114-3C717162-BC79-488D-9064-23E604027CA5Q33248391-5D88856C-8837-458D-B4A7-E0351F79D490Q33249813-FA99F549-3AAB-4701-8926-6AAC0A5DD8FAQ33270398-A41250CE-67C6-4118-8018-E024D819B9B4Q33280035-76D8E480-C44B-41E1-A7CE-BB3A9AAA5C71Q33286060-4EBC5E07-472B-4D98-8093-E7330DEE7BA2Q33299697-55ED2730-D61C-42F7-967E-785056355343Q33313887-265D14E5-566A-4BA3-A633-E79F0B8B6DDD
P2860
Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Recursive partitioning analysi ...... RTOG) brain metastases trials.
@en
type
label
Recursive partitioning analysi ...... RTOG) brain metastases trials.
@en
prefLabel
Recursive partitioning analysi ...... RTOG) brain metastases trials.
@en
P2093
P1476
Recursive partitioning analysi ...... RTOG) brain metastases trials.
@en
P2093
McKenna WG
Phillips T
Wasserman T
P304
P356
10.1016/S0360-3016(96)00619-0
P407
P577
1997-03-01T00:00:00Z